COVID-19 Vaccine Research

Want to know more about vaccine development and other COVID-19 research?

Do you and your neighbors have questions about COVID-19 vaccines? With the first approved vaccines now available and clinical trials continuing to advance around the world, the Rutgers Institute for Health, Health Care Policy and Aging Research is available to provide up-to-date scientific information about COVID-19 vaccines and research.

Community organizations and groups interested in hosting a virtual discussion with IFH experts or seeking guest speakers for important conversations, please contact community@ifh.rutgers.edu.

Join the IFH Community to stay connected to the Institute and receive the latest news and events, opportunities for studies, information on health issues and resources, and to learn more about our ongoing work. Click here.


COVID-19 is affecting every community differently. Some areas are much harder-hit than others. To find out what is happening where you live, check out Emory University’s COVID-19 Health Equity Interactive Dashboard.

Click here.

Frequently Asked Questions: Clinical Research

What is a clinical study?

Interventions that have shown promise in the laboratory and then in animal models subsequently move on to research studies in people, also known as clinical studies. The COVID-19 Prevention Network (CoVPN) will be doing studies to find safe and effective vaccines and monoclonal antibodies for the severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2), which is the virus that causes coronavirus disease 2019 (COVID-19).

These vaccines and antibodies cannot cause SARS-CoV-2 infection or COVID-19 illness. They do not contain any live or killed virus. Participants in these studies may be exposed to the virus in their everyday lives, but they will not be exposed to the virus as part of the study (known as “challenge studies.”) These are studies of preventive vaccines that we hope will keep people healthy.

¿Qué es un estudio clínico?

Los medicamentos y las vacunas que han demostrado ser prometedoras en el laboratorio y luego en ser probadas en modelos animales, pasan a estudios de investigación en humanos, también conocidos como estudios clínicos. La Red de Prevención COVID-19 (CoVPN) llevará a cabo estudios clínicos para encontrar una vacuna segura y efectiva para el coronavirus del síndrome respiratorio agudo severo tipo 2 (SARS-COV-2), que es el virus que causa la enfermedad por Coronavirus 2019 (COVID- 19).

Estas vacunas y anticuerpos no causan la infección SARS-CoV-2 o la enfermedad COVID-19. Tampoco contienen el virus vivo o muerto. Los participantes de estos estudios podrían exponerse al virus en su vida diaria , pero no serán expuestos al virus como parte del estudio (conocidos como “Ensayos de Exposición”). Estos estudios son para el desarrollo de vacunas preventivas que esperamos mantengan a las personas sanas.  Para más información de los estudios actualmente activos, por favor consulta la lista a continuación.

Is joining a COVID-19 vaccine or antibody study like being a guinea pig?

Unlike guinea pigs, people can say yes or no about joining a study. All study volunteers must go through a process called informed consent that ensures they understand all of the risks and benefits of being in a study, and those volunteers are reminded that they may leave a study at any time without losing any of their rights or benefits. The COVID-19 Prevention Network (CoVPN) takes great care to make sure people understand the study fully before they decide whether or not to join. All CoVPN studies follow US federal regulations on research, as well as international ethical standards and any country-specific requirements for the countries where our research is conducted.

¿Participar en un estudio de vacuna o anticueropo COVID-19 es como ser unconejillo de Indias?

A diferente de los conejillos de Indias, las personas pueden decir sí o no acerca de participar a un estudio. Todos los voluntarios del estudio deben pasar por un proceso llamado consentimiento informado que garantiza que comprenden todos los riesgos y beneficios de participar en un estudio, y se les recuerda que pueden retirarse un estudio en cualquier momento sin perder ninguno de sus derechos o beneficios. La Red de Prevención COVID-19 (CoVPN) se asegura de que las personas entiendan el estudio completamente antes de decidir si se participaran o no. Todos los estudios de CoVPN siguen las regulaciones federales de los EE. UU. sobre el investigación, así como los estándares éticos internacionales y los requisitos específicos de cada país donde se realiza nuestra investigación.

Source: https://coronaviruspreventionnetwork.org/
Published: Aug. 30, 2020